The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The ‘cytokine profile’: a code for sepsis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y. (2001) · Science · doi:10.1126/science.1061781 · Cited by 332
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Self-citationNicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228
Self-citationShock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Self-citationMultiple Organ Dysfunction Score: A reliable descriptor of a complex clinical outcome
Marshall, J. C., Cook, D. J., Christou, N. V., Bernard, G. R., Sprung, C. L., & Sibbald, W. J. (1995) · Critical Care Medicine · doi:10.1097/00003246-199510000-00007 · Cited by 2,532
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Self-citationCaspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citationKindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
Self-citationReversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
Self-citationTumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Self-citationThe interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783
Tumor Necrosis Factor, Other Cytokines and Disease
Tracey, K. J., & Cerami, A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001533 · Cited by 783
Self-citationNovel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation
Abraham, E., Arcaroli, J., Carmody, A., Wang, H., & Tracey, K. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2950 · Cited by 692
Self-citationDevelopment of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Has the mortality of septic shock changed with time?
Friedman, G., Silva, E., & Vincent, J.-L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00045 · Cited by 607
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C. J., Fink, M. P., & Tracey, K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192222999 · Cited by 585
Self-citationCalandra, T., Baumgartner, J.-D., Grau, G. E., Wu, M.-M., Lambert, P.-H., Schellekens, J., Verhoef, J., Glauser, M. P., & Swiss-Dutch J5 Immunoglobulin Study Group (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.982 · Cited by 547
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
Baker, C. C., Chaudry, I. H., Gaines, H. O., & Baue, A. E. (1983) · PubMed · Cited by 506
Degryse, B., Bonaldi, T., Scaffidi, P., Müller, S., Resnati, M., Sanvito, F., Arrigoni, G., & Bianchi, M. E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1197 · Cited by 451
Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms
Saleh, M., Vaillancourt, J. P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S., et al. (2004) · Nature · doi:10.1038/nature02451 · Cited by 422
Alice in caspase land. A phylogenetic analysis of caspases from worm to man
Lamkanfi, M. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400989 · Cited by 397
Caspase‐activation pathways in apoptosis and immunity
Creagh, E. M., Conroy, H., & Martin, S. J. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00048.x · Cited by 382
Abraham, E., Matthay, M. A., Dinarello, C. A., Vincent, J.-L., Cohen, J., Opal, S. M., Glauser, M., Parsons, P., Fisher, C. J., & Repine, J. E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200001000-00039 · Cited by 372
Marks, J. D., Marks, C. B., Ljuce, J. M., Montgomery, A. B., Turner, J., Metz, C. A., & Murray, J. F. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.1.94 · Cited by 328
Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., & Remick, D. G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2724 · Cited by 323
Sappington, P. L., Yang, R., Yang, H., Tracey, K. J., Delude, R. L., & Fink, M. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.35391 · Cited by 320
Self-citationAbraham, E., Laterre, P.-F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00006 · Cited by 293
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
Kokkola, R., Sundberg, E., Ulfgren, A. ‐., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X. ‐., Furie, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10540 · Cited by 290
Self-citationvan der Poll, T., & Lowry, S. F. (1995) · Shock · doi:10.1097/00024382-199501000-00001 · Cited by 230
Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins
Miyazono, K., Maeda, S., & Imamura, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207131 · Cited by 182
Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock
Ombrellino, M., Wang, H., Ajemian, M. S., Talhouk, A., Scher, L. A., Friedman, S. G., & Tracey, K. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02658-6 · Cited by 168
Self-citationRemick, D., Manohar, P., Bolgos, G., Rodriguez, J., Moldawer, L., & Wollenberg, G. (1995) · Shock · doi:10.1097/00024382-199508000-00002 · Cited by 164
Matot, I., & Sprung, C. L. (2001) · Intensive Care Medicine · doi:10.1007/pl00003795 · Cited by 153
Recombinant HMGB1 with cytokine-stimulating activity
Li, J., Wang, H., Mason, J. M., Levine, Y. A., Yu, M., Ulloa, L., Czura, C. J., Tracey, K. J., & Yang, H. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.019 · Cited by 151
Self-citationSmad7 in TGF-β-mediated negative regulation of gut inflammation
Monteleone, G., Pallone, F., & MacDonald, T. T. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.008 · Cited by 136
Ulloa, L., Batliwalla, F., Andersson, U., Gregersen, P. K., & Tracey, K. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10854 · Cited by 87
Self-citationAt the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1
Bustin, M. (2002) · Science Signaling · doi:10.1126/stke.2002.151.pe39 · Cited by 84
Autoantibodies to Nucleosomal Proteins: Antibodies to HMG-17 in Autoimmune Diseases
Bustin, M., Reisch, J. C., Einck, L., & Klippel, J. H. (1982) · Science · doi:10.1126/science.6460317 · Cited by 75
Current concepts in the role of the host response in Neisseria meningitidis septic shock
Brandtzaeg, P., & van Deuren, M. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200206000-00006 · Cited by 67
Anti-TNF agents in Crohn’s disease
Assche, G. V., & Rutgeerts, P. J. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.1.103 · Cited by 64
Fang, W., Yao, Y.-M., Shi, Z., Yu, Y., Wu, Y., Lu, L.-R., & Sheng, Z. (2002) · Shock · doi:10.1097/00024382-200204000-00016 · Cited by 58
HMGB1 in the Immunology of Sepsis (Not Septic Shock) and Arthritis
Czura, C. J., Yang, H., Amella, C. A., & Tracey, K. J. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)84005-7 · Cited by 55
Self-citationMatthay, M. A., & Ware, L. B. (2004) · Nature Medicine · doi:10.1038/nm1104-1161 · Cited by 52
Lipid unites disparate syndromes of sepsis
Wang, H., Czura, C. J., & Tracey, K. J. (2004) · Nature Medicine · doi:10.1038/nm0204-124 · Cited by 44
Self-citationEthyl pyruvate: a novel treatment for sepsis and shock.
Fink, M. (2004) · PubMed · Cited by 34
High Mobility Group Box–1 as a Therapeutic Target Downstream of Tumor Necrosis Factor
Czura, C. J., Yang, H., & Tracey, K. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/374753 · Cited by 33
Self-citation
Cited by
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
“To determine whether nitric oxide might act through guanylyl cyclase in the BMSCs, we pretreated these cells with 1H-[1,2,4]oxadiazolo[4,3-a] quinoxalin-1-one (ODQ), an irreversible inhibitor of soluble guanylyl cyclase35 (Fig.”
Regulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Animal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Prockop, D. J., & Youn Oh, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.211 · Cited by 816
Metadata
- Authors
- Ulloa, L., & Tracey, K. J.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 11
- Issue
- 2
- Pages
- 56-63
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2035355922
- Cited by
- 440
- References
- 62
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.